Last reviewed · How we verify

NCT02481102: EASYER

EASYER (EpiAccess SYstem Registry) A Post Market Observational Registry

Completed Last updated 10 February 2021
What this trial tests

trial in Arrhythmias, Cardiac in 36 participants. Completed in 9 February 2021.

Timeline
30 June 2015
Primary endpoint
9 February 2021
9 February 2021

Quick facts

Lead sponsorEpiEP, Inc.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment36
Start date30 June 2015
Primary completion9 February 2021
Estimated completion9 February 2021
Sites3 locations across United States

Conditions studied

Sponsor

EpiEP, Inc.

Who can join

18 and older, any sex, with Arrhythmias, Cardiac. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of the Registry is to provide post market clinical outcome and potential health economics data and confirm the continued safety of the EpiAccess system.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Arrhythmias, Cardiac

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02481102.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing